Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

被引：2489

作者：

Olive, Kenneth P. ^{[1
]}

Jacobetz, Michael A. ^{[1
]}

Davidson, Christian J. ^{[2
]}

Gopinathan, Aarthi ^{[1
,2
]}

McIntyre, Dominick ^{[1
]}

Honess, Davina ^{[1
]}

Madhu, Basetti ^{[1
]}

Goldgraben, Mae A. ^{[1
]}

Caldwell, Meredith E. ^{[1
]}

Allard, David ^{[1
]}

Frese, Kristopher K. ^{[1
]}

DeNicola, Gina ^{[1
,2
]}

Feig, Christine ^{[1
]}

Combs, Chelsea ^{[2
]}

Winter, Stephen P. ^{[1
]}

Ireland-Zecchini, Heather ^{[1
]}

Reichelt, Stefanie ^{[1
]}

Howat, William J. ^{[1
]}

Chang, Alex ^{[3
,4
,5
]}

Dhara, Mousumi ^{[3
,4
,5
]}

Wang, Lifu ^{[2
,6
]}

Rueckert, Felix ^{[7
]}

Gruetzmann, Robert ^{[7
]}

Pilarsky, Christian ^{[7
]}

Izeradjene, Kamel ^{[8
,9
]}

Hingorani, Sunil R. ^{[8
,9
]}

Huang, Pearl ^{[10
]}

Davies, Susan E. ^{[11
]}

Plunkett, William ^{[12
]}

Egorin, Merrill ^{[13
]}

Hruban, Ralph H. ^{[3
,4
,5
]}

Whitebread, Nigel ^{[14
]}

McGovern, Karen ^{[14
]}

Adams, Julian ^{[14
]}

Iacobuzio-Donahue, Christine ^{[3
,4
,5
]}

Griffiths, John ^{[1
]}

Tuveson, David A. ^{[1
]}

机构：

[1] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 ORE, England

[2] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA

[3] Sidney Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21287 USA

[4] Sidney Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA

[5] Johns Hopkins Univ, Baltimore, MD 21287 USA

[6] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai 200025, Peoples R China

[7] Univ Hosp Dresden, Dept Surg, D-01307 Dresden, Germany

[8] Fred Hutchinson Canc Res Ctr, Clin Res & Publ Hlth Sci Div, Seattle, WA 98109 USA

[9] Univ Washington, Seattle, WA 98109 USA

[10] Merck & Co Inc, Oncol Franchise, N Wales, PA 19454 USA

[11] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England

[12] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[13] Univ Pittsburgh, Med Ctr, Div Hematol & Oncol, Pittsburgh, PA 15213 USA

[14] Infin Pharmaceut, Cambridge, MA 01239 USA

来源：

SCIENCE | 2009年 / 324卷 / 5933期

关键词：

DUCTAL ADENOCARCINOMA; SONIC HEDGEHOG; GEMCITABINE; GROWTH; METASTASIS; DIAGNOSIS; SURVIVAL; THERAPY; TUMORS; TRIAL;

D O I：

10.1126/science.1171362

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Pancreatic ductal adenocarcinoma (PDA) is among the most lethal human cancers in part because it is insensitive to many chemotherapeutic drugs. Studying a mouse model of PDA that is refractory to the clinically used drug gemcitabine, we found that the tumors in this model were poorly perfused and poorly vascularized, properties that are shared with human PDA. We tested whether the delivery and efficacy of gemcitabine in the mice could be improved by coadministration of IPI-926, a drug that depletes tumor-associated stromal tissue by inhibition of the Hedgehog cellular signaling pathway. The combination therapy produced a transient increase in intratumoral vascular density and intratumoral concentration of gemcitabine, leading to transient stabilization of disease. Thus, inefficient drug delivery may be an important contributor to chemoresistance in pancreatic cancer.

引用

页码：1457 / 1461

页数：5

共 27 条

[1] A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY OF GEMCITABINE
ABBRUZZESE, JL
GRUNEWALD, R
WEEKS, EA
GRAVEL, D
ADAMS, T
NOWAK, B
MINEISHI, S
TARASSOFF, P
SATTERLEE, W
RABER, MN
PLUNKETT, W
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) : 491 - 498
[2] Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Bailey, Jennifer M.
Swanson, Benjamin J.
Hamada, Tomofumi
Eggers, John P.
Singh, Pankaj K.
Caffery, Thomas
Ouellette, Michel M.
Hollingsworth, Michael A.
[J]. CLINICAL CANCER RESEARCH, 2008, 14 (19) : 5995 - 6004
[3] Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice
Bruns, CJ
Shrader, M
Harbison, MT
Portera, C
Solorzano, CC
Jauch, KW
Hicklin, DJ
Radinsky, R
Ellis, LM
[J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (02) : 101 - 108
[4] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
Burris, HA
Moore, MJ
Andersen, J
Green, MR
Rothenberg, ML
Madiano, MR
Cripps, MC
Portenoy, RK
Storniolo, AM
Tarassoff, P
Nelson, R
Dorr, FA
Stephens, CD
VanHoff, DD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2403 - 2413
[5] K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses
Cook, Natalie
Olive, Kenneth R.
Frese, Kristopher
Tuveson, David A.
[J]. SMALL GTPASES IN DISEASE, PT B, 2008, 439 : 73 - +
[6] Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs
Duan, Jian-Xin
Jiao, Hailong
Kaizerman, Jacob
Stanton, Timothy
Evans, James W.
Lan, Leslie
Lorente, Gustavo
Banica, Monica
Jung, Don
Wang, Jinwei
Ma, Huaiyu
Li, Xiaoming
Yang, Zhijian
Hoffman, Robert M.
Ammons, W. Steve
Hart, Charles P.
Matteucci, Mark
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) : 2412 - 2420
[7] EGORIN MJ, 1974, CANCER RES, V34, P2243
[8] Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
Hingorani, SR
Wang, LF
Multani, AS
Combs, C
Deramaudt, TB
Hruban, RH
Rustgi, AK
Chang, S
Tuveson, DA
[J]. CANCER CELL, 2005, 7 (05) : 469 - 483
[9] Pathology of genetically engineered mouse models of pancreatic exocrine cancer:: Consensus report and recommendations
Hruban, RH
Adsay, NV
Albores-Saavedra, J
Anver, MR
Biankin, AV
Boivin, GP
Furth, EE
Furukawa, T
Klein, A
Klimstra, DS
Klöppel, G
Lauwers, GY
Longnecker, DS
Lüttges, J
Maitra, A
Offerhaus, GJA
Pérez-Gallego, L
Redston, M
Tuveson, DA
[J]. CANCER RESEARCH, 2006, 66 (01) : 95 - 106
[10] Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
Johnson, JI
Decker, S
Zaharevitz, D
Rubinstein, LV
Venditti, J
Schepartz, S
Kalyandrug, S
Christian, M
Arbuck, S
Hollingshead, M
Sausville, EA
[J]. BRITISH JOURNAL OF CANCER, 2001, 84 (10) : 1424 - 1431

← 1 2 3 →